<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="trma" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">trma</book-part-id>
      <title-group>
        <title>Thiamine-Responsive Megaloblastic Anemia Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Rogers Syndrome, TRMA</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Oishi</surname>
            <given-names>Kimihiko</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Departments of Pediatrics and Genetics and Genomic Sciences<break/>Icahn School of Medicine at Mount Sinai<break/>New York, New York</aff>
          <email>kimihiko.oishi@mountsinai.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Diaz</surname>
            <given-names>George A</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Genetics and Genomic Sciences<break/>Icahn School of Medicine at Mount Sinai<break/>New York, New York</aff>
          <email>george.diaz@mssm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>10</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>4</day>
          <month>5</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>19</day>
          <month>11</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="td" document-type="chapter">Thanatophoric Dysplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="tar" document-type="chapter">Thrombocytopenia Absent Radius Syndrome</related-object>
      <abstract id="trma.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic, and anemia can recur when treatment is withdrawn. Progressive sensorineural hearing loss has generally been early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may delay onset of diabetes in some individuals.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of TRMA is established in a proband (with or without diabetes or hearing loss):</p>
          <list list-type="bullet">
            <list-item>
              <p>With megaloblastic anemia and normal vitamin B<sub>12</sub>/folic acid levels in whom there is a response to oral thiamine; and/or</p>
            </list-item>
            <list-item>
              <p>By identification of biallelic pathogenic variants in <italic toggle="yes">SLC19A2</italic> by molecular genetic testing.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Lifelong use of pharmacologic doses (50-100 mg/day) of oral thiamine (vitamin B<sub>1</sub>) in affected individuals regardless of age. Red blood cell transfusion for severe anemia.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Complications secondary to poor glycemic control for diabetes or chronic anemia may occur. Ongoing management of the primary disease is essential.</p>
          <p><italic toggle="yes">Surveillance</italic>: At least yearly monitoring of the efficacy of the oral thiamine therapy and of disease progression, including: hematologic tests (CBC, reticulocyte count); assessment for glucose intolerance (fasting serum glucose concentration, OGTT, urine analysis); and hearing, ophthalmologic, and cardiac evaluations.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Good diabetic control prior to and during pregnancy is recommended.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>TRMA is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which the <italic toggle="yes">SLC19A2</italic> pathogenic variants have been identified in the affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="trma.Diagnosis">
        <title>Diagnosis</title>
        <sec id="trma.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) <bold>should be suspected in</bold> individuals with the following triad of clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Megaloblastic anemia</bold> occurring between infancy and adolescence:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Examination of the bone marrow reveals megaloblastic changes with erythroblasts often containing iron-filled mitochondria (ringed sideroblasts).</p>
                </list-item>
                <list-item>
                  <p>Vitamin B<sub>12</sub>/folic acid levels are normal</p>
                </list-item>
                <list-item>
                  <p>The anemia is corrected with pharmacologic doses of thiamine (vitamin B<sub>1</sub>) (50-100 mg/day). However, the red cells remain macrocytic, suggesting a persistent erythropoietic abnormality [<xref ref-type="bibr" rid="trma.REF.haworth.1982.549">Haworth et al 1982</xref>, <xref ref-type="bibr" rid="trma.REF.neufeld.1997.1335">Neufeld et al 1997</xref>]; anemia can recur when thiamine is withdrawn.</p>
                </list-item>
                <list-item>
                  <p>Even without thiamine supplementation, serum thiamine concentrations are normal; there is no evidence of acidosis or aciduria.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Progressive sensorineural deafness.</bold> Hearing loss is generally early and has been detected in toddlers. Whether hearing loss is congenital (prelingual) is unknown. Some affected individuals have signs of megaloblastic anemia and diabetes at an early age, but no hearing loss.</p>
            </list-item>
            <list-item>
              <p><bold>Diabetes mellitus</bold> that is non-type I in nature, with age of onset from infancy to adolescence. Insulin secretion is present but defective [<xref ref-type="bibr" rid="trma.REF.valerio.1998.38">Valerio et al 1998</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="trma.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of TRMA <bold>is established</bold> in a proband with megaloblastic anemia with normal vitamin B<sub>12</sub>/folic acid levels, with or without diabetes or hearing loss in whom there is a response to oral thiamine and/or identification of biallelic pathogenic variants in <italic toggle="yes">SLC19A2</italic> by molecular genetic testing (see <xref ref-type="table" rid="trma.T.molecular_genetic_testing_used_in">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">SLC19A2</italic> is performed first and followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">SLC19A2</italic> and other genes of interest (see <xref ref-type="sec" rid="trma.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene varies by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="trma.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Thiamine-Responsive Megaloblastic Anemia Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SLC19A2</italic>
                  </td>
                  <td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Nearly 100%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Very rare; observed in 1 family to date&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="trma.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="trma" object-id="trma.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="trma.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="trma.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="trma.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="trma.TF.1.4">
                <label>4. </label>
                <p>Nearly all individuals with the diagnostic phenotypic triad evaluated by sequence analysis have identifiable pathogenic variants in <italic toggle="yes">SLC19A2</italic>. To date, more than 40 families with 33 distinct pathogenic variants have been identified [<xref ref-type="bibr" rid="trma.REF.diaz.1999.309">Diaz et al 1999</xref>, <xref ref-type="bibr" rid="trma.REF.raz.2000.37">Raz et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.scharfe.2000.669">Scharfe et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.gritli.2001.508">Gritli et al 2001</xref>, <xref ref-type="bibr" rid="trma.REF.neufeld.2001.135">Neufeld et al 2001</xref>, <xref ref-type="bibr" rid="trma.REF.ozdemir.2002.205">Ozdemir et al 2002</xref>, <xref ref-type="bibr" rid="trma.REF.lagarde.2004.299">Lagarde et al 2004</xref>, <xref ref-type="bibr" rid="trma.REF.ricketts.2006.99">Ricketts et al 2006</xref>, <xref ref-type="bibr" rid="trma.REF.bergmann.2009.888">Bergmann et al 2009</xref>, <xref ref-type="bibr" rid="trma.REF.onal.2009.301">Onal et al 2009</xref>, <xref ref-type="bibr" rid="trma.REF.pichler.2012.1711">Pichler et al 2012</xref>, <xref ref-type="bibr" rid="trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>, <xref ref-type="bibr" rid="trma.REF.yilmaz_agladioglu.2012.149">Yilmaz Agladioglu et al 2012</xref>]. Homozygosity by descent has been the most common finding. Seven individuals from six families were compound heterozygotes with distinct pathogenic variants from each parent [<xref ref-type="bibr" rid="trma.REF.bergmann.2009.888">Bergmann et al 2009</xref>, <xref ref-type="bibr" rid="trma.REF.pichler.2012.1711">Pichler et al 2012</xref>, <xref ref-type="bibr" rid="trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>].</p>
              </fn>
              <fn id="trma.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="trma.TF.1.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="trma.REF.beshlawi.2014.528">Beshlawi et al [2014]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="trma.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="trma.Clinical_Description">
          <title>Clinical Description</title>
          <p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus.</p>
          <list list-type="bullet">
            <list-item>
              <p>The earliest findings of significant bone marrow problems (see <xref ref-type="sec" rid="trma.Suggestive_Findings">Suggestive Findings</xref>) have been in the first year of life and the latest in teenage years.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Peripheral blood count shows a pattern of macrocytic anemia with low hemoglobin and high mean corpuscular volume (MCV) in the absence of deficiencies of folate or vitamin B<sub>12</sub>.</p>
                </list-item>
                <list-item>
                  <p>Bone marrow shows dysplastic hematopoiesis with numerous megaloblasts.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Hearing defects may be present at an early age and in some families may even be present at birth [<xref ref-type="bibr" rid="trma.REF.setoodeh.2013.295">Setoodeh et al 2013</xref>]. Progressive sensorineural hearing loss is irreversible and may not be prevented by thiamine treatment. The basis of the sensorineural deafness is obscure; it is not known if the deafness is caused by abnormalities of the cochlea or of the auditory nerve. However, animal studies suggest that selective inner hair cell loss in the cochlea could be the cause of hearing defects in TRMA [<xref ref-type="bibr" rid="trma.REF.liberman.2006.211">Liberman et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p>Non-type I diabetes mellitus has appeared before school age in many (though not all) individuals with glycosuria and hyperglycemia. Diabetic ketoacidosis has been reported in a few cases [<xref ref-type="bibr" rid="trma.REF.kurto_lu.2008.393">Kurto&#x0011f;lu et al 2008</xref>, <xref ref-type="bibr" rid="trma.REF.pomaha_ov_.2016">Pomaha&#x0010d;ov&#x000e1; et al 2016</xref>]. Initially, patients respond to oral hypoglycemic agents but most become insulin dependent in the long term.</p>
            </list-item>
          </list>
          <p>In addition to the triad of clinical features that characterize TRMA, other findings have been observed, each in only a subset of individuals:</p>
          <list list-type="bullet">
            <list-item>
              <p>Optic atrophy, when commented on in case reports, appears common. Abnormal appearance of the retina and functional retinal dystrophy have been reported [<xref ref-type="bibr" rid="trma.REF.meire.2000.243">Meire et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.kipioti.2003.105">Kipioti et al 2003</xref>, <xref ref-type="bibr" rid="trma.REF.lagarde.2004.299">Lagarde et al 2004</xref>]. The kindred reported as having DIDMOAD (<italic toggle="yes">d</italic>iabetes <italic toggle="yes">i</italic>nsipidus, <italic toggle="yes">d</italic>iabetes <italic toggle="yes">m</italic>ellitus, <italic toggle="yes">o</italic>ptic <italic toggle="yes">a</italic>trophy, and <italic toggle="yes">d</italic>eafness) by <xref ref-type="bibr" rid="trma.REF.borgnapignatti.1989.405">Borgna-Pignatti et al [1989]</xref> has in retrospect been shown by genetic analysis to have TRMA; optic atrophy was not known to be a finding of TRMA at the time (see <xref ref-type="sec" rid="trma.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
            <list-item>
              <p>Cardiovascular abnormalities including sudden death, stroke, high-output heart failure, paroxysmal atrial tachycardia, atrial standstill, and congenital heart defects such as atrial septal defect or ventricular septal defect have been reported in 27% of individuals with TRMA [<xref ref-type="bibr" rid="trma.REF.villa.2000.947">Villa et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.lorber.2003.476">Lorber et al 2003</xref>, <xref ref-type="bibr" rid="trma.REF.lagarde.2004.299">Lagarde et al 2004</xref>, <xref ref-type="bibr" rid="trma.REF.aycan.2011.144">Aycan et al 2011</xref>, <xref ref-type="bibr" rid="trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Significant neurologic deficit including stroke and focal or generalized epilepsy has been reported during early childhood in 27% of individuals with TRMA [<xref ref-type="bibr" rid="trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="trma.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlation has been discerned.</p>
        </sec>
        <sec id="trma.Nomenclature">
          <title>Nomenclature</title>
          <p>The synonym &#x0201c;Rogers syndrome&#x0201d; derives from the first report of the disease in a child with diabetes mellitus, sensorineural deafness, and megaloblastic anemia who responded to thiamine (vitamin B<sub>1</sub>) treatment.</p>
          <p>One case report suggests &#x0201c;thiamine-responsive myelodysplasia&#x0201d; as an alternative name for the syndrome [<xref ref-type="bibr" rid="trma.REF.bazarbachi.1998.1098">Bazarbachi et al 1998</xref>].</p>
        </sec>
        <sec id="trma.Prevalence">
          <title>Prevalence</title>
          <p>Approximately 50 pedigrees are known.</p>
          <p>TRMA is exceedingly rare outside of consanguineous families or isolated populations. Cases have been observed in various ethnicities including Israeli Arab and Lebanese populations, an Alaskan kindred of native and ethnic Russian descent, and kindreds from Brazil, Japan, Oman, Tunisia, Italy (Venetian and other), Iran, India, and Pakistan, as well as Kashmiri families in Great Britain, ethnic Kurds, persons of northern European heritage, and African Americans [<xref ref-type="bibr" rid="trma.REF.raz.2000.37">Raz et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.neufeld.2001.135">Neufeld et al 2001</xref>, <xref ref-type="bibr" rid="trma.REF.lagarde.2004.299">Lagarde et al 2004</xref>, <xref ref-type="bibr" rid="trma.REF.bergmann.2009.888">Bergmann et al 2009</xref>, <xref ref-type="bibr" rid="trma.REF.pichler.2012.1711">Pichler et al 2012</xref>, <xref ref-type="bibr" rid="trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</xref>, <xref ref-type="bibr" rid="trma.REF.yilmaz_agladioglu.2012.149">Yilmaz Agladioglu et al 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="trma.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">SLC19A2</italic>.</p>
      </sec>
      <sec id="trma.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The combination of megaloblastic red cell changes and ringed sideroblasts in individuals with thiamine-responsive megaloblastic anemia syndrome (TRMA) is unique among anemias influenced by metabolic or nutritional causes. Among acquired anemias, this combination is most suggestive of myelodysplastic syndromes in which megaloblastosis and sideroblasts are often noted. TRMA should not be confused with myelodysplastic disorders of premalignant potential.</p>
        <p>Phenotypic overlap exists between TRMA and <related-object link-type="booklink" source-id="gene" document-id="wfs" document-type="chapter">Wolfram syndrome</related-object>, or DIDMOAD (<italic toggle="yes">d</italic>iabetes <italic toggle="yes">i</italic>nsipidus, <italic toggle="yes">d</italic>iabetes <italic toggle="yes">m</italic>ellitus, <italic toggle="yes">o</italic>ptic <italic toggle="yes">a</italic>trophy, and <italic toggle="yes">d</italic>eafness), including diabetes mellitus, optic atrophy, and deafness. Notably missing in Wolfram syndrome are megaloblastic anemia and thiamine responsiveness. Wolfram syndrome is caused by pathogenic variants in <italic toggle="yes">WFS1</italic>. The encoded protein is a novel transmembrane glycoprotein of 100 kd located in the endoplasmic reticulum, where it is thought to play a role in membrane trafficking, protein processing, or regulation of calcium homeostasis.</p>
        <p>The combination of diabetes mellitus and deafness calls to mind mitochondrial disorders [<xref ref-type="bibr" rid="trma.REF.fischelghodsian.1999.261">Fischel-Ghodsian 1999</xref>], but the macrocytic anemia, megaloblastic bone marrow, and response to thiamine distinguish TRMA from these disorders (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">book-part://mt-overview/</related-object>). Inheritance in TRMA is unequivocally autosomal recessive, which sets it apart from disorders with apparent maternal transmission and mitochondrial inheritance.</p>
      </sec>
      <sec id="trma.Management">
        <title>Management</title>
        <sec id="trma.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with thiamine-responsive megaloblastic anemia syndrome (TRMA), the following evaluations are recommended if they have not already been completed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Peripheral blood count and bone marrow analysis for evidence of megaloblastic anemia</p>
            </list-item>
            <list-item>
              <p>Serum folate concentration, serum vitamin B<sub>12</sub> concentration, and serum iron studies to exclude other entities</p>
            </list-item>
            <list-item>
              <p>Hearing test</p>
            </list-item>
            <list-item>
              <p>Fasting serum glucose concentration, oral glucose tolerance test (OGTT), and urinalysis to diagnose diabetes mellitus</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation, including echocardiography</p>
            </list-item>
            <list-item>
              <p>Neuroimaging including brain MRI when clinically indicated</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="trma.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <sec id="trma.Thiamine">
            <title>Thiamine</title>
            <p>Management focuses on lifelong use of pharmacologic doses (50-100 mg/day) of oral thiamine (vitamin B<sub>1</sub>) in affected individuals regardless of age.</p>
            <p>High-dose thiamine supplementation:</p>
            <list list-type="bullet">
              <list-item>
                <p>Invariably improves the hematologic picture;</p>
              </list-item>
              <list-item>
                <p>Did not prevent the development of hearing loss in infants with TRMA in some studies [<xref ref-type="bibr" rid="trma.REF.borgnapignatti.2009.295">Borgna-Pignatti et al 2009</xref>, <xref ref-type="bibr" rid="trma.REF.ak_n.2011.36">Ak&#x00131;n et al 2011</xref>]. The efficacy of high-dose thiamine in improving hearing or delaying hearing loss has been difficult to study and remains unclear.</p>
              </list-item>
              <list-item>
                <p>May delay onset of diabetes mellitus, and may ameliorate diabetes mellitus in the short term and perhaps even for decades [<xref ref-type="bibr" rid="trma.REF.valerio.1998.38">Valerio et al 1998</xref>]. Insulin requirements are reduced with thiamine therapy in some cases [<xref ref-type="bibr" rid="trma.REF.neufeld.1997.1335">Neufeld et al 1997</xref>].</p>
              </list-item>
              <list-item>
                <p>Has not been evaluated as a treatment for optic atrophy, cardiovascular abnormalities, or neurologic abnormalities associated with TRMA.</p>
              </list-item>
            </list>
          </sec>
          <sec id="trma.Additional_Treatment">
            <title>Additional Treatment</title>
            <p>Red blood cell transfusion for severe anemia is indicated.</p>
            <p>See <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object> for treatment strategies for hearing loss. Treatment has included cochlear implant [<xref ref-type="bibr" rid="trma.REF.hagr.2014.78">Hagr 2014</xref>].</p>
            <p>Diabetes, cardiovascular abnormalities, and neurologic disorders should be treated in the standard manner.</p>
          </sec>
        </sec>
        <sec id="trma.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>See <xref ref-type="sec" rid="trma.Treatment_of_Manifestations">Treatment of Manifestations</xref>.</p>
        </sec>
        <sec id="trma.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Complications secondary to poor glycemic control for diabetes or chronic anemia may occur. Ongoing management of the primary disease is essential.</p>
        </sec>
        <sec id="trma.Surveillance">
          <title>Surveillance</title>
          <p>The following are recommended at least yearly to monitor the efficacy of the oral thiamine therapy as well as disease progression:</p>
          <list list-type="bullet">
            <list-item>
              <p>Hematologic tests (CBC, reticulocyte count)</p>
            </list-item>
            <list-item>
              <p>Hearing test</p>
            </list-item>
            <list-item>
              <p>Assessment for glucose intolerance (fasting serum glucose concentration, OGTT, urinalysis)</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation</p>
            </list-item>
          </list>
        </sec>
        <sec id="trma.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of sibs of an affected individual by molecular genetic testing of the <italic toggle="yes">SLC19A2</italic> pathogenic variants in the family in order to identify those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>Supplementation with pharmacologic doses of thiamine (vitamin B<sub>1</sub>) (25-75 mg/day compared to US RDA of 1.5 mg/day) is recommended as early as possible for at-risk sibs until their genetic status can be determined.</p>
          <p>See <xref ref-type="sec" rid="trma.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="trma.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>While there are no published studies evaluating pregnancy outcome in affected women, good diabetic control prior to and during pregnancy is recommended.</p>
        </sec>
        <sec id="trma.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="trma.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="trma.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="trma.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SLC19A2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with TRMA are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">SLC19A2</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of an <italic toggle="yes">SLC19A2</italic> pathogenic variant.</p>
        </sec>
        <sec id="trma.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">SLC19A2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="trma.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="trma.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="trma.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SLC19A2</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for TRMA are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="trma.Resources">
        <title>Resources</title>
      </sec>
      <sec id="trma.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="trma.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Defect of a high-affinity thiamine transporter, SLC19A2, causes TRMA; however, it is still unclear how the absence of <italic toggle="yes">SLC19A2</italic> expression results in the seemingly divergent disorders of megaloblastic anemia, diabetes mellitus, and deafness. Biochemical studies on fibroblasts or erythrocytes from individuals with TRMA showed that absence of the high-affinity component of thiamine transport results in low intracellular thiamine concentrations [<xref ref-type="bibr" rid="trma.REF.rindi.1992.231">Rindi et al 1992</xref>, <xref ref-type="bibr" rid="trma.REF.stagg.1999.723">Stagg et al 1999</xref>]. Defective RNA ribose synthesis caused by intracellular thiamine deficiency is thought to be the cause of megaloblastic changes in TRMA [<xref ref-type="bibr" rid="trma.REF.boros.2003.3556">Boros et al 2003</xref>]. <italic toggle="yes">Slc19a2</italic> knockout mouse models have been developed [<xref ref-type="bibr" rid="trma.REF.oishi.2002.2951">Oishi et al 2002</xref>, <xref ref-type="bibr" rid="trma.REF.fleming.2003.234">Fleming et al 2003</xref>]; the animal models manifest megaloblastic changes, diabetes mellitus, and sensorineural deafness (the main features of TRMA) when dietary thiamine levels are decreased [<xref ref-type="bibr" rid="trma.REF.oishi.2002.2951">Oishi et al 2002</xref>]. While the mechanism of megaloblastic changes is still to be elucidated, these models showed defects in insulin secretion and selective loss of inner hair cells in cochlea [<xref ref-type="bibr" rid="trma.REF.oishi.2002.2951">Oishi et al 2002</xref>, <xref ref-type="bibr" rid="trma.REF.liberman.2006.211">Liberman et al 2006</xref>].</p>
          <p>Questions regarding TRMA disease pathogenesis that still require explanation include why individuals with TRMA do not have manifestations seen in dietary thiamine deficiency [<xref ref-type="bibr" rid="trma.REF.mandel.1984.836">Mandel et al 1984</xref>, <xref ref-type="bibr" rid="trma.REF.poggi.1984.153">Poggi et al 1984</xref>, <xref ref-type="bibr" rid="trma.REF.abboud.1985.537">Abboud et al 1985</xref>] and why the findings in TRMA are organ specific.</p>
          <p>Studies showed that a second high-affinity thiamine transporter, encoded by <italic toggle="yes">SLC19A3</italic>, has major roles in intestinal thiamine uptake in mouse, accounting for the absence of overt thiamine deficiency in persons with TRMA [<xref ref-type="bibr" rid="trma.REF.reidling.2010.1802">Reidling et al 2010</xref>]. In support of this, two Japanese brothers with a Wernicke&#x02019;s-like encephalopathy were reported to have compound heterozygous pathogenic variants in <italic toggle="yes">SLC19A3</italic> [<xref ref-type="bibr" rid="trma.REF.kono.2009.1792">Kono et al 2009</xref>]. In addition, the difference in distribution of expression of the two thiamine transporters is critical in TRMA: in pancreatic endocrine cells, the expression of <italic toggle="yes">SLC19A2</italic> is much higher than that of <italic toggle="yes">SLC19A3</italic> and TRMA-associated <italic toggle="yes">SLC19A2</italic> mutated alleles disrupt thiamine uptake significantly [<xref ref-type="bibr" rid="trma.REF.mee.2009.g197">Mee et al 2009</xref>]. Similarly, it is hypothesized that in TRMA, the other affected tissues (namely, bone marrow and cochlea) do not express or minimally express <italic toggle="yes">SLC19A3</italic> [<xref ref-type="bibr" rid="trma.REF.eudy.2000.581">Eudy et al 2000</xref>, <xref ref-type="bibr" rid="trma.REF.rajgopal.2001.175">Rajgopal et al 2001</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SLC19A2</italic> spans approximately 22.5 kb and has six exons with a 237-bp 5' UTR and a 1,620-bp 3' UTR [<xref ref-type="bibr" rid="trma.REF.diaz.1999.309">Diaz et al 1999</xref>, <xref ref-type="bibr" rid="trma.REF.dutta.1999.31925">Dutta et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="trma" object-id="trma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold>
<italic toggle="yes">SLC19A2</italic> pathogenic variants are distributed throughout the gene with no apparent clustering or mutation hot spots. The majority of <italic toggle="yes">SLC19A2</italic> pathogenic variants known to date are predicted to be null for protein because of pathogenic nonsense or frameshift variants and missense variants which would likely severely disrupt the folding and membrane targeting of the transporter. Additionally, some splicing variants and small deletion/duplication variants have been reported. Consistently, <xref ref-type="bibr" rid="trma.REF.balamurugan.2002.g37">Balamurugan &#x00026; Said [2002]</xref> showed that introducing several of these pathogenic variants into transfected HeLa cells resulted in impaired thiamine uptake.</p>
          <p><bold>Normal gene product.</bold> The 497-amino acid protein, the high-affinity thiamine transporter 1, is predicted to have 12 transmembrane domains.</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants result in either a truncated protein from a premature stop codon or aberrantly folded protein caused by missense variants in transmembrane domains.</p>
        </sec>
      </sec>
      <sec id="trma.References">
        <title>References</title>
        <sec id="trma.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="trma.Literature_Cited.reflist0">
            <ref id="trma.REF.abboud.1985.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abboud</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najjar</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity.</article-title>
                <source>J Pediatr</source>
                <volume>107</volume>
                <fpage>537</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">4045602</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.ak_n.2011.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ak&#x00131;n</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurto&#x0011f;lu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kendirci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ak&#x00131;n</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karak&#x000fc;k&#x000e7;&#x000fc;</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?</article-title>
                <source>J Clin Res Pediatr Endocrinol.</source>
                <volume>3</volume>
                <fpage>36</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21448333</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.aycan.2011.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aycan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ba&#x0015f;</surname>
                    <given-names>VN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetinkaya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>A&#x0011f;ladio&#x0011f;lu</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kendirci</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senocak</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report.</article-title>
                <source>J Pediatr Hematol Oncol.</source>
                <volume>33</volume>
                <fpage>144</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21285901</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.balamurugan.2002.g37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balamurugan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Functional role of specific amino acid residues in human thiamine transporter SLC19A2: mutational analysis.</article-title>
                <source>Am J Physiol Gastrointest Liver Physiol</source>
                <volume>283</volume>
                <fpage>G37</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">12065289</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.bazarbachi.1998.1098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bazarbachi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muakkit</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salem</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haidar</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Thiamine-responsive myelodysplasia.</article-title>
                <source>Br J Haematol</source>
                <volume>102</volume>
                <fpage>1098</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">9734663</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.bergmann.2009.888">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahai</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcone</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgna-Pignati</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hexner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathews</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wierenga</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.</article-title>
                <source>J Pediatr.</source>
                <volume>155</volume>
                <fpage>888</fpage>
                <lpage>92.e1</lpage>
                <pub-id pub-id-type="pmid">19643445</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.borgnapignatti.2009.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borgna-Pignatti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzalli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedretti</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.</article-title>
                <source>J Pediatr.</source>
                <volume>155</volume>
                <fpage>295</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19619756</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.borgnapignatti.1989.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borgna-Pignatti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marradi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monetti</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Thiamine-responsive anemia in DIDMOAD syndrome.</article-title>
                <source>J Pediatr</source>
                <volume>114</volume>
                <fpage>405</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">2537896</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.beshlawi.2014.528">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beshlawi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Zadjali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elshinawy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alrawas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wali</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Thiamine responsive megaloblastic anemia: the puzzling phenotype.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>61</volume>
                <fpage>528</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24249281</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.boros.2003.3556">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boros</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinkamp</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cascante</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA).</article-title>
                <source>Blood</source>
                <volume>102</volume>
                <fpage>3556</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">12893755</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.diaz.1999.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banikazemi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oishi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelb</surname>
                    <given-names>BD</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>22</volume>
                <fpage>309</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">10391223</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.dutta.1999.31925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dutta</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molero</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kekuda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leibach</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devoe</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganapathy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <article-title>Cloning of the human thiamine transporter, a member of the folate transporter family.</article-title>
                <source>J Biol Chem.</source>
                <year>1999</year>
                <volume>274</volume>
                <fpage>31925</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10542220</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.eudy.2000.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eudy</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegelstein</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wlodarczyk</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finnell</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes.</article-title>
                <source>Mol Genet Metab</source>
                <volume>71</volume>
                <fpage>581</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11136550</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.fischelghodsian.1999.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischel-Ghodsian</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mitochondrial deafness mutations reviewed.</article-title>
                <source>Hum Mutat</source>
                <volume>13</volume>
                <fpage>261</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10220138</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.fleming.2003.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawatsuji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bednarski</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.</article-title>
                <source>Mol Genet Metab</source>
                <volume>80</volume>
                <fpage>234</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">14567973</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.gritli.2001.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gritli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guannouni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinkamp</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berul</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hafsia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jilani</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belhani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.</article-title>
                <source>Br J Haematol</source>
                <volume>113</volume>
                <fpage>508</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">11380424</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.hagr.2014.78">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hagr</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Cochlear implant and thiamine-responsive megaloblastic anemia syndrome.</article-title>
                <source>Ann Saudi Med</source>
                <volume>34</volume>
                <fpage>78</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">24658560</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.haworth.1982.549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haworth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitra</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wickramasinghe</surname>
                    <given-names>SN</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Thiamine responsive anaemia: a study of two further cases.</article-title>
                <source>Br J Haematol</source>
                <volume>50</volume>
                <fpage>549</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">6175336</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.kipioti.2003.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kipioti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffbrand</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheridan</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cone-rod dystrophy in thiamine-responsive megaloblastic anemia.</article-title>
                <source>J Pediatr Ophthalmol Strabismus</source>
                <volume>40</volume>
                <fpage>105</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12691235</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.kono.2009.1792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Togawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirakawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy.</article-title>
                <source>N Engl J Med.</source>
                <volume>360</volume>
                <fpage>1792</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19387023</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.kurto_lu.2008.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurto&#x0011f;lu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatipoglu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keskin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kendirci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akcakus</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <year>2008</year>
                <volume>21</volume>
                <fpage>393</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18556972</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.lagarde.2004.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lagarde</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Underwood</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moats-Staats</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calikoglu</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>125A</volume>
                <fpage>299</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">14994241</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.liberman.2006.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liberman</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.</article-title>
                <source>J Assoc Res Otolaryngol.</source>
                <volume>7</volume>
                <fpage>211</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16642288</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.lorber.2003.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazit</surname>
                    <given-names>AZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoury</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome.</article-title>
                <source>Pediatr Cardiol</source>
                <volume>24</volume>
                <fpage>476</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">14627317</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.mandel.1984.836">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berant</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hazani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naveh</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Thiamine-dependent beriberi in the "thiamine-responsive anemia syndrome."</article-title>
                <source>N Engl J Med</source>
                <volume>311</volume>
                <fpage>836</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6472386</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.mee.2009.g197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mee</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabokina</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekar</surname>
                    <given-names>VT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramanian</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maedler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: studies using mice and human pancreatic preparations.</article-title>
                <source>Am J Physiol Gastrointest Liver Physiol</source>
                <volume>297</volume>
                <fpage>G197</fpage>
                <lpage>206</lpage>
                <pub-id pub-id-type="pmid">19423748</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.meire.2000.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Genderen</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemmens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ens-Dokkum</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>21</volume>
                <fpage>243</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">11135496</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.neufeld.2001.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinkamp</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.</article-title>
                <source>Blood Cells Mol Dis</source>
                <volume>27</volume>
                <fpage>135</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11358373</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.neufeld.1997.1335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szargel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yandava</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stagg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faure</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buist</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>1335</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9399900</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.oishi.2002.2951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oishi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manwani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlassara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelb</surname>
                    <given-names>BD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2951</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">12393806</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.onal.2009.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Onal</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bari&#x0015f;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozdil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye&#x0015f;il</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozyilmaz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celkan</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.</article-title>
                <source>Turk J Pediatr.</source>
                <volume>51</volume>
                <fpage>301</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19817279</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.ozdemir.2002.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ozdemir</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akcakus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurtoglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunes</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torun</surname>
                    <given-names>YA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature.</article-title>
                <source>Pediatr Diabetes</source>
                <volume>3</volume>
                <fpage>205</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15016149</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.pichler.2012.1711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pichler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeitlhofer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dworzak</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diakos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kager</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2012</year>
                <volume>171</volume>
                <fpage>1711</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22576805</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.poggi.1984.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeVizia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andria</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rindi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandro</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Thiamin-responsive megaloblastic anaemia: a disorder of thiamin transport?</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>7</volume>
                <supplement>Suppl 2</supplement>
                <fpage>153</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">6090807</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.pomaha_ov_.2016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pomaha&#x0010d;ov&#x000e1;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zamboryov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000fd;kora</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paterov&#x000e1;</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fikl&#x000ed;k</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Votava</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x0010c;ern&#x000e1;</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jehli&#x0010d;ka</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e1;d</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x00160;ubrt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dort</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dortov&#x000e1;</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T&#x0003e;G.</article-title>
                <source>Pediatr Diabetes.</source>
                <year>2016</year>
                <month>Dec</month>
                <day>22</day>
                <comment>Epub ahead of print</comment>
                <pub-id pub-id-type="pmid">28004468</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.rajgopal.2001.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rajgopal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edmondnson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>SLC19A3 encodes a second thiamine transporter ThTr2.</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1537</volume>
                <fpage>175</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11731220</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.raz.2000.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labay</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szargel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anbinder</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabl</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viana</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruchel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cayuela</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.</article-title>
                <source>Hum Mutat</source>
                <volume>16</volume>
                <fpage>37</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">10874303</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.reidling.2010.1802">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reidling</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambrecht</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kassir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Impaired intestinal vitamin B(1) (thiamin) uptake in thiamin transporter-2-deficient mice.</article-title>
                <source>Gastroenterology.</source>
                <volume>138</volume>
                <fpage>1802</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19879271</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.ricketts.2006.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minton</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariyawansa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wales</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrett</surname>
                    <given-names>TG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.</article-title>
                <source>Acta Paediatr</source>
                <volume>95</volume>
                <fpage>99</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">16373304</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.rindi.1992.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rindi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casirola</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vizia</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforenza</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Thiamine transport by erythrocytes and ghosts in thiamine-responsive megaloblastic anaemia.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>15</volume>
                <fpage>231</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">1326679</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.scharfe.2000.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scharfe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauschild</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidemann</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaksch</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I.</article-title>
                <source>J Med Genet</source>
                <volume>37</volume>
                <fpage>669</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">10978358</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.setoodeh.2013.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Setoodeh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haghighi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saleh-Gohari</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haghighi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.</article-title>
                <source>Gene</source>
                <volume>519</volume>
                <fpage>295</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23454484</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.shawsmith.2012.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shaw-Smith</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patch</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grulich-Henn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habeb</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomahacova</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdullah</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.</article-title>
                <source>Pediatr Diabetes.</source>
                <volume>13</volume>
                <fpage>314</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">22369132</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.stagg.1999.723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stagg</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.</article-title>
                <source>J Clin Invest</source>
                <volume>103</volume>
                <fpage>723</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10074490</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.valerio.1998.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Valerio</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franzese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenore</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.</article-title>
                <source>Diabetes Care</source>
                <volume>21</volume>
                <fpage>38</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9538968</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.villa.2000.947">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivellese</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Salle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iovine</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capaldo</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>85</volume>
                <fpage>947</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10720020</pub-id>
              </element-citation>
            </ref>
            <ref id="trma.REF.yilmaz_agladioglu.2012.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yilmaz Agladioglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aycan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bas</surname>
                    <given-names>VN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltek Kendirci</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onder</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.</article-title>
                <source>Genet Couns.</source>
                <volume>23</volume>
                <fpage>149</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">22876572</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="trma.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="trma.Author_History">
          <title>Author History</title>
          <p>George A Diaz, MD, PhD (2006-present) Judith C Fleming, PhD; Children's Hospital and Harvard Medical School (2003-2006) Ellis J Neufeld, MD, PhD; Children's Hospital and Harvard Medical School (2003-2006) Kimihiko Oishi, MD (2006-present)</p>
        </sec>
        <sec id="trma.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>4 May 2017 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 November 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 April 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 November 2007 (cd) Revision: sequence analysis and prenatal diagnosis available clinically for <italic toggle="yes">SCL19A2</italic></p>
            </list-item>
            <list-item>
              <p>22 June 2006 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 October 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 August 2003 (ejn) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
